Perennial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Perennial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-662	Closed	-$44K	–	106
2021 Q2	$44K	Hold	662	–	–	0.01%	158
2021 Q1	$42K	Buy	662 +201	+44%	+$12.5K	0.01%	157
2020 Q4	$29K	Buy	+461	New	+$28.3K	0.01%	163
2020 Q3	–	Sell	-461	Closed	-$27K	–	94
2020 Q2	$27K	Buy	+461	New	+$27.6K	0.01%	157
2019 Q1	–	Sell	-461	Closed	-$24K	–	94
2018 Q4	$24K	Hold	461	–	–	0.02%	124
2018 Q3	$29K	Hold	461	–	–	0.02%	123
2018 Q2	$26K	Hold	461	–	–	0.02%	128
2018 Q1	$29K	Hold	461	–	–	0.02%	121
2017 Q4	$28K	Hold	461	–	–	0.02%	130
2017 Q3	$29K	Hold	461	–	–	0.02%	115
2017 Q2	$26K	Hold	461	–	–	0.02%	122
2017 Q1	$25K	Hold	461	–	–	0.02%	114
2016 Q4	$27K	Buy	+461	New	+$25.2K	0.02%	110

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Perennial Advisors's BMY Position: Q3 2021 in Review

Perennial Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 662 shares — an estimated $44K sold.

Perennial Advisors first reported a position in BMY in Q4 2016 and held it in 13 quarters. The position peaked at $44K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Perennial Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Perennial Advisors sold 662 Bristol-Myers Squibb shares in Q3 2021, an estimated $44K.
Perennial Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 13 quarters.
Perennial Advisors's Bristol-Myers Squibb position peaked at $44K in Q2 2021.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Perennial Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.